Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Birte Möhlendick"'
Autor:
Christian Dohna-Schwake, Birte Möhlendick, Winfried Siffert, Michael M. Schündeln, Burcin Dogan, Ivana Radulovic
Publikováno v:
Pharmacogenetics and genomics. 31(6)
Metamizole is a widely prescribed NSAID with excellent analgesic and antipyretic properties. Although very effective, it is banned in some countries because of the risk for severe agranulocytosis. We here describe three patients with metamizole-assoc
Autor:
Wolfram T. Knoefel, Andreas Krieg, Irene Esposito, Timm J. Filler, Levent Dizdar, Sina C. Schütte, Birte Möhlendick, Jasmin Drusenheimer, Thomas A. Werner
Publikováno v:
Neuroendocrinology. 107:246-256
Background: Gastroenteropancreatic neuroendocrine carcinomas (GEP-NECs) are biologically aggressive tumors, associated with a very poor survival. Due to their rarity, our knowledge on GEP-NEC biology is very limited. The aim of this study was to esta
Autor:
Bernhard Polzer, Wolfram T. Knoefel, Birte Möhlendick, Christoph Klein, Jakob R. Izbicki, S. Schumacher, Matthias Maneck, Martin Hoffmann, Gero Brockhoff, Nikolas H. Stoecklein, Thomas Schamberger, Sophie Pasch
Publikováno v:
International Journal of Cancer. 142:833-843
Early metastatic dissemination and evolution of disseminated cancer cells (DCCs) outside the primary tumor is one reason for the failure of adjuvant therapies because it generates molecular geno- and phenotypes different from primary tumors which sti
Autor:
C Driemel, Matthias U. Kassack, Rui P L Neves, Thomas Krahn, Irene Esposito, Oliver von Ahsen, Claudia Hille, Nora Brychta, Michael Drosch, Birte Möhlendick, Johannes C. Fischer, Nikolas H. Stoecklein, Antje Stresemann, Wolfram T. Knoefel
Publikováno v:
Oncotarget
It is now widely recognized that the isolation of circulating tumor cells based on cell surface markers might be hindered by variability in their protein expression. Especially in pancreatic cancer, isolation based only on EpCAM expression has produc
Autor:
Sivagurunathan Sutharsan, Frank Herbstreit, Andreas Kribben, Winfried Siffert, Karsten Schmidt, Katharina Breuckmann, Carina Elsner, Kristina Schönfelder, Karl-Heinz Jöckel, Joachim Risse, Ulf Dittmer, Birte Möhlendick, Christian Taube, David Fistera
Publikováno v:
Cytokine
Background and aims The interferon-induced transmembrane protein 3 (IFITM3) plays an important role in the adaptive and innate immune response by inhibiting viral membrane hemifusion between the host and viral cell cytoplasm. Single nucleotide polymo
Autor:
Levent Dizdar, Birte Möhlendick, S. Schumacher, C. Vay, Daniel Will, Daniel Vallböhmer, Nikolas H. Stoecklein, Wolfram T. Knoefel, Johannes C. Fischer, Christoph Bartenhagen, Georg Fluegen, Martin Hoffmann, Christoph Klein, Stephan Baldus
Publikováno v:
British Journal of Cancer
Background: Chromosomal instability (CIN) has repeatedly been identified as a prognostic marker. Here we evaluated the percentage of aberrant genome per cell (PAG) as a measure of CIN in single disseminated tumour cells (DTC) isolated from patients w
Autor:
Wolfram T. Knoefel, Andreas Krieg, Levent Dizdar, Sina C. Schütte, Nikolas H. Stoecklein, Thomas A. Werner, Stefan A. Topp, Birte Möhlendick, Pablo E. Verde, Irene Esposito, Jasmin C. Riemer, Kira A. Oesterwind, Sabrina Mersch, Katharina Raba
Publikováno v:
Oncotarget
// Levent Dizdar 1 , Kira A. Oesterwind 1 , Jasmin C. Riemer 2 , Thomas A. Werner 1 , Sabrina Mersch 1 , Birte Mohlendick 1 , Sina C. Schutte 1 , Pablo E. Verde 3 , Katharina Raba 4 , Stefan A. Topp 1 , Nikolas H. Stoecklein 1 , Irene Esposito 2 , Wo
Autor:
Alberto Ferrarini, Johann S. de Bono, Claudio Forcato, Nikolas H. Stoecklein, Valentina del Monaco, Chiara Bolognesi, Genny Buson, Rui Neves, Maryou B. Lambros, Gianni Medoro, Andrea Ardizzoni, Birte Möhlendick, Penny Flohr, Nicolò Manaresi, Karim Rihawi, Mario Terracciano, Paola Tononi, Francesca Fontana, Semini Sumanasuriya
Publikováno v:
PLoS ONE, Vol 13, Iss 3, p e0193689 (2018)
PLoS ONE
PLoS ONE
Chromosomal instability and associated chromosomal aberrations are hallmarks of cancer and play a critical role in disease progression and development of resistance to drugs. Sin- gle-cell genome analysis has gained interest in latest years as a sour
Autor:
Gard O. S. Thomassen, Olga Zaikova, Leonardo A. Meza-Zepeda, Jinchang Sun, Tale Barøy, Birte Möhlendick, Ragnhild A. Lothe, Peter J. Campbell, Torfinn Nome, Adrienne M. Flanagan, Lynnette Fernandez-Cuesta, Rolf Inge Skotheim, Terje Cruickshank Ahlquist, Ola Myklebost, Anne Mari Håkelien, Harald Rieder, Karoly Szuhai, Susanne Lorenz, Jan Christian Bryne, Daniel Vodak, Patrick S. Tarpey
Publikováno v:
Oncotarget, 7(5), 5273-5288
ResearcherID
Oncotarget
ResearcherID
Oncotarget
In contrast to many other sarcoma subtypes, the chaotic karyotypes of osteosarcoma have precluded the identification of pathognomonic translocations. We here report hundreds of genomic rearrangements in osteosarcoma cell lines, showing clear characte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bb7e166c4080cb0c4584f492a0b18d6
http://hdl.handle.net/1887/111899
http://hdl.handle.net/1887/111899
Autor:
Patric Kröpil, Stefan A. Topp, Markus P. Ghadimi, Nikolas H. Stoecklein, Sabrina Mersch, Helmut E. Gabbert, Hany Ashmawy, Wolfram T. Knoefel, Jasmin C. Riemer, Andreas Krieg, Birte Möhlendick, Tanja Arent, Philipp M. Schlünder
Publikováno v:
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 37(2)
Approximately 50-70 % of patients with retroperitoneal or intraabdominal sarcoma develop a relapse after surgical therapy, including peritoneal sarcomatosis, an extremely rare site of metastatic disease which is associated with an extremely poor prog